The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics. WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version. The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal. WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%. |
Person arrested after threat plunges Tauranga Hospital into fiveUnlicensed Hastings driver toppled motorcyclist, drove over him, causing fatal injuries, then fledNairobi fire: At least 29 injured in Kenya gas plant explosionFree trade deal with India challenging but not impossibleNelson urgently needs revitalisation as economic performance slumpsSensitive NZ Police video evidence shuffled around US tech companiesLower Hutt longGrammys 2024: Photos from the 66th annual awardsBaby Ru: Police contact whānau after three months of silenceTe reo Māori: Govt seeks to halt extra pay for public servants fluent in the language